Skip to main content
. 2020 Jan 22;8:e8458. doi: 10.7717/peerj.8458

Table 1. Correlation between immunohistochemical variables and clinicopathologic features of ICC patients in the cohort (n = 322).

Characteristics CD68+ TAMs CD86+ TAMs CD206+ TAMs
Low High P# Low High P# Low High P#
Age, years
≤51 88 81 0.503 87 82 0.655 79 90 0.264
>51 73 80 74 79 82 71
Gender
Female 69 59 0.305 57 71 0.139 71 57 0.139
Male 92 102 104 90 90 104
Hepatitis history
No 104 94 0.303 94 104 0.303 100 98 0.909
Yes 57 67 67 57 61 63
CA199 (U/ml)
≤36 85 72 0.181 67 90 0.014 86 71 0.118
>36 76 89 94 71 75 90
Lymph node metastasis
No 135 131 0.659 124 142 0.012 143 123 0.005
Yes 26 30 37 19 18 38
Liver cirrhosis
No 121 115 0.529 107 129 0.008 126 110 0.058
Yes 40 46 54 32 35 51
Tumor size (cm)
≤5 75 70 0.654 75 70 0.654 80 65 0.117
>5 86 91 86 91 81 96
Tumor number
Single 121 123 0.897 120 124 0.697 123 121 0.897
Multiple 40 38 41 37 38 40
Vascular invasion
No 135 141 0.426 133 143 0.151 145 131 0.038
Yes 26 20 28 18 16 30
Tumor encapsulation
None 146 137 0.171 145 138 0.305 141 142 1.000
Complete 15 24 16 23 20 19
Tumor differentiation
I–II 127 122 0.595 122 127 0.595 127 122 0.595
III 34 39 39 34 34 39
TNM stage
I + II 129 119 0.233 116 132 0.046 137 111 0.001
III + IV 32 42 45 29 24 50

Notes:

ICC, intrahepatic cholangiocarcinoma; TNM, tumor-node-metastasis.

Bold values indicate P < 0.05.

#

The Pearson Chi square test was applied.

HHS Vulnerability Disclosure